论文信息 - Defining Radioiodine-Refractory Differentiated Thyroid Cancer: Efficacy and Safety of Lenvatinib by Radioiodine-Refractory Criteria in the SELECT Trial - 字舞流文

Defining Radioiodine-Refractory Differentiated Thyroid Cancer: Efficacy and Safety of Lenvatinib by Radioiodine-Refractory Criteria in the SELECT Trial

Sung-Bae Kim | M. Shah | B. Robinson | M. Tahara | N. Kiyota | A. Hoff | C. Dutcus | Di Li | Matthew H. Taylor | E. Lee